Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, F R Appelbaum et al.|Blood|1999Cited by 456
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Stephen J. Forman et al.|Blood|1999Cited by 439
SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S.K. Sutherland, Julie A. McEarchern, Roland B. Walter et al.|Blood|2013Cited by 385
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.Oliver W. Press, Irwin D. Bernstein, Darning Shan et al.|PubMed|1996Cited by 212
Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomicsBrandon Hadland, Irwin D. Bernstein|Nature Communications|2022Cited by 54